Cartiva

Cartiva, Inc. is a privately-held orthopaedic medical device company dedicated to improving the quality of life of patients with osteoarthritis, cartilage damage and other musculoskeletal conditions. Based in Alpharetta, Georgia, Cartiva's lead product, a unique synthetic cartilage implant, received U.S. Premarket Approval (PMA) in July 2016 for its initial indication, osteoarthritis at the base of the great toe.